|
BTG Plc - Comparative Business Analysis Snapshot
Business Description
BTG Plc. The Group's principal activity developing and commercialising life science technologies. The Group in-licenses, develops and commercialises pharmaceuticals and has a broad pipeline of development programme targeting neurological and other disorders including varicose veins. It acquires the rights to early-stage pharmaceuticals and other medical technologies from a global network of corporations, universities and research institutions. The drug development programme are in the field of oncology, ageing, neuroscience and drug repositioning. The Group's products are Varisolve, Misopess, Benefix, Campath, Infecton, Juvidex and Symadex.
Competitor Analysis
This analysis compares BTG Plc with three other companies in closely related industry sectors.
The full Comparative Business Report is available to Subscribers or may be purchased individually. The full report generally includes the following sections:
- Sales Analysis: Recent Sales, Sales Growth, Sales per Employee
- Recent Stock Performance
- Company Valuation Ratios: Price/Earnings, Price/Book Value
- Price/Sales and 52 Week Price change
- Dividend Analysis
- Profitability Analysis: Gross Profit Margin, EBITDA Margin
- Earnings Before Extraordinary Items
- Inventory Analysis
- Research and Development Expenses
- Financial Position: Long Term Debt/Equity, Days Accounts Receivable, Days Inventory
- R&D Expenses/Sales
Not the Report you are looking for? Click here for more browsing options.
|
